<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32567251</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1942-7611</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drug testing and analysis</Title>
          <ISOAbbreviation>Drug Test Anal</ISOAbbreviation>
        </Journal>
        <ArticleTitle>An unusual detection of tert-butyl-4-anilinopiperidine-1-carboxylate in seizures of falsified 'Xanax' tablets and in items in a suspected heroin seizure submitted by Irish law enforcement.</ArticleTitle>
        <Pagination>
          <StartPage>1387</StartPage>
          <EndPage>1392</EndPage>
          <MedlinePgn>1387-1392</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/dta.2884</ELocationID>
        <Abstract>
          <AbstractText>The identification of tert-butyl-4-anilinopiperidine-1-carboxylate (4-anilinopiperdine-t-BOC or 4-AP-t-BOC) in many seized falsified 'Xanax' tablets has been reported after being encountered in forensic casework in late 2019 and early 2020 in Ireland. This substance was also detected in a pink powder submitted for analysis in March 2020. The pink powder was part of a larger seizure comprising brown powders which contained morphine or diamorphine (heroin) or a type of counterfeit heroin or heroin adulterant (known as 'bash'). Novel benzodiazepines and other substances are being detected as ingredients in falsified benzodiazepine tablets more frequently on the illicit market. The detection of 4-AP-t-BOC in benzodiazepine tablets is noteworthy and 4-AP-t-BOC is added to the list of adulterants found in benzodiazepine tablets emerging in Europe. The presence of 4-AP-t-BOC in both falsified 'Xanax' and powdered seizures is unusual, and analytical data are presented to assist with the identification of this compound in suspected illicit substances. The presence of 4-AP-t-BOC in the tablets was confirmed using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry analyses, and spectral fragmentation pathways were suggested. To the authors' best knowledge, information about the biological activity of 4-AP-t-BOC is not available. The removal of the t-BOC protecting group yields 4-anilinopiperidine which has been reported to be involved in the synthesis of fentanyl.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons, Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>May</LastName>
            <ForeName>Colette</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0002-7908-9137</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Justice and Equality, Forensic Science Ireland, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Downey</LastName>
            <ForeName>Carol</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Justice and Equality, Forensic Science Ireland, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Power</LastName>
            <ForeName>John D</ForeName>
            <Initials>JD</Initials>
            <Identifier Source="ORCID">0000-0003-0926-1621</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Justice and Equality, Forensic Science Ireland, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kavanagh</LastName>
            <ForeName>Pierce V</ForeName>
            <Initials>PV</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St. James Hospital, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>07</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Drug Test Anal</MedlineTA>
        <NlmUniqueID>101483449</NlmUniqueID>
        <ISSNLinking>1942-7603</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D058110">Counterfeit Drugs</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013287">Illicit Drugs</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013607">Tablets</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>70D95007SX</RegistryNumber>
          <NameOfSubstance UI="D003932">Heroin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>UF599785JZ</RegistryNumber>
          <NameOfSubstance UI="D005283">Fentanyl</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>YU55MQ3IZY</RegistryNumber>
          <NameOfSubstance UI="D000525">Alprazolam</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000525" MajorTopicYN="N">Alprazolam</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002853" MajorTopicYN="N">Chromatography, Liquid</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058110" MajorTopicYN="N">Counterfeit Drugs</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004340" MajorTopicYN="Y">Drug Contamination</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005283" MajorTopicYN="N">Fentanyl</DescriptorName>
          <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008401" MajorTopicYN="N">Gas Chromatography-Mass Spectrometry</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003932" MajorTopicYN="N">Heroin</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013287" MajorTopicYN="N">Illicit Drugs</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007494" MajorTopicYN="N" Type="Geographic">Ireland</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013058" MajorTopicYN="N">Mass Spectrometry</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013607" MajorTopicYN="N">Tablets</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">4-anilinopiperidine-t-BOC</Keyword>
        <Keyword MajorTopicYN="N">falsified ‘Xanax’</Keyword>
        <Keyword MajorTopicYN="N">fentanyl</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32567251</ArticleId>
        <ArticleId IdType="doi">10.1002/dta.2884</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Drugsdata.org (Erowid's anonymous drug analysis program- Formerly called Ecstacydata). Search for Sample ID 7518, 8162, 7540, 8015, 7517 and 7996. Available at: https://www.ecstasydata.org/results.php?start=0&amp;search_field=all&amp;s=xanax. Accessed on June 13, 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Drug Enforcement Agency (DEA). Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals, 2019. Federal Register, Office of the Federal Register, National Archives and Records Administration, pp. 48314-48321.</Citation>
        </Reference>
        <Reference>
          <Citation>Gupta PK, Manral L, Ganesan K, Malhorta RC, Sekhar K. A Method for the Preparation of Fentanyl European patent, 09721316.9, 2013. https://patents.google.com/patent/EP2252149A2/en</Citation>
        </Reference>
        <Reference>
          <Citation>International Narcotics Control Board. Red list 16th Edition. List of Precursors and chemicals Frequently used in the illicit manufacture of narcotic drugs and psychotropic substances under International Control. Available at: https://www.incb.org/documents/PRECURSORS/RED_LIST/RedList_16thEd_Jan2018_E.pdf Accessed on June 13, 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Wolf C, Villalobos CN, Cummings PG, Kennedy-Gabb S, Olsen MA, Trescher G. Elucidation of the presence and location of t-Boc protecting groups in amines and dipeptides using on-column H/D exchange HPLC/ESI/MS. J am Soc Mass Spectrom. 2005;16(4):553-564. https://doi.org/10.1016/j.jasms.2005.01.008</Citation>
        </Reference>
        <Reference>
          <Citation>Seck R, Gassama A, Cojean S, Cavé C. Synthesis and antimalarial activity of 1,4-disubstituted piperidine derivatives. Molecules. 2020;25(2):21-26. https://doi.org/10.3390/molecules25020299</Citation>
        </Reference>
        <Reference>
          <Citation>Lee HY, An KM, Jung J, et al. Identification of novel aminopiperidine derivatives for antibacterial activity against gram-positive bacteria. Bioorganic Med Chem Lett. 2016;26(13):3148-3152. https://doi.org/10.1016/j.bmcl.2016.04.086</Citation>
        </Reference>
        <Reference>
          <Citation>Mayr's Database of Reactivity. Aliphatic amines available at: https://www.cup.lmu.de/oc/mayr/reaktionsdatenbank/fe/showclass/41 and aromatic amines available at: https://www.cup.lmu.de/oc/mayr/reaktionsdatenbank/fe/showclass/42. Accessed on June 13, 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Fisher Scientific. Amine Protection/Deprotection. Available at: https://www.fishersci.co.uk/gb/en/scientific-products/lab-reporter-europe/chemicals/amine-protection-deprotection.html. Accessed on June 13, 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang J, Liang YL, Qu J. Boiling water-catalyzed neutral and selective N-Boc deprotection. Chem Commun. 2009;34(34):5144-5146. https://doi.org/10.1039/b910239f</Citation>
        </Reference>
        <Reference>
          <Citation>Janssen PAJ. Method for producing analgesia. US Patent 3,141,823. 1964.</Citation>
        </Reference>
        <Reference>
          <Citation>Gupta PK, Ganesan K, Pande A, Malhotra RC. A convenient one pot synthesis of fentanyl. J Chem Research. 2005;99:452-453.</Citation>
        </Reference>
        <Reference>
          <Citation>Valdez CA, Leif RN, Mayer BP. An efficient, optimized synthesis of fentanyl and related analogs. PLoS One. 2014;9(9):2-9. https://doi.org/10.1371/journal.pone.0108250</Citation>
        </Reference>
        <Reference>
          <Citation>Mayer BP, DeHope AJ, Mew DA, Spackman PE, Williams AM. Chemical attribution of fentanyl using multivariate statistical analysis of orthogonal mass spectral data. Anal Chem. 2016;88(8):4303-4310. https://doi.org/10.1021/acs.analchem.5b04434</Citation>
        </Reference>
        <Reference>
          <Citation>Lurie IS, Berrier AL, Casale JF, Iio R, Bozenko JS. Profiling of illicit fentanyl using UHPLC-MS/MS. Forensic Sci Int. 2012;220(1-3):191-196. https://doi.org/10.1016/j.forsciint.2012.02.024</Citation>
        </Reference>
        <Reference>
          <Citation>Mayer A, Copp B, Bogun B, Miskelly G. Identification and characterization of chemically masked derivatives of pseudoephedrine, ephedrine, methamphetamine, and MDMA. Drug Test Anal. 2020;12(4):524-537. https://doi.org/10.1002/dta.2764</Citation>
        </Reference>
        <Reference>
          <Citation>Collins M, Donnelly C, Cameron S, Tahtouh M, Salouros H. Identification and characterization of N-tert-butoxycarbonyl-MDMA: a new MDMA precursor. Drug Test Anal. 2017;9(3):399-404. https://doi.org/10.1002/dta.2059</Citation>
        </Reference>
        <Reference>
          <Citation>International Narcotics Control Board. Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychoactive substances 2018. Available at: https://www.incb.org/documents/PRECURSORS/TECHNICAL_REPORTS/2018/Report/E_ebook_with_annexes.pdf Accessed June 13, 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Drug Enforcement Agency. Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals. 2020, Federal Register, Office of the Federal Register, National Archives and Records Administration, pp. 20822-20829.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
